President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

Medicaid doesn’t need price controls from other countries; it already imposes them here. Under the program’s existing “Best ...

The Chief Medical Director of Phalycon Clinic in Bauchi, Dr Hassan Garba, has attributed the rising costs of consumables and ...

Pharmaceutical companies have little incentive to sell drugs to countries that can’t afford them. But bargaining together can ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

The Centers for Medicare & Medicaid Services recently began meeting with patients who use the 15 drugs it selected for the ...

President Donald Trump’s executive order, which threatens pharmaceutical companies with targeted retaliation and lawsuits if ...

Organon faces profitability challenges and revenue declines. The valuation appears fair given the weak revenue outlook. See ...

Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...

Boston-based Verve is a rare example of a gene editing company targeting a disease that affects a large population, offering ...

Exactly 10 years ago Monday, Donald Trump descended an escalator and announced his run for president, a moment many now see ...

AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now. On June 12, the US Food and Drug Administration (FDA) approved the company’s Mavyret treatment label expansion. The approval ...